关于老年人共病的一种新的理论假说——交感神经过度兴奋疾病（DSO）。
A Novel Theoretical Hypothesis on Comorbidity in the Elderly-The Disease of Sympathetic Overdrive (DSO).
作者信息
Jie Li, Jian Kong, Boxin Yu, Hongyang Li
机构信息
Department of Elderly and Cadrethe First Hospital of Jilin University Changchun China.
Department of General Practice First Hospital of Jilin University Changchun China.
出版信息
Aging Med (Milton). 2025 Jul 9;8(4):370-374. doi: 10.1002/agm2.70026. eCollection 2025 Aug.
Abstract
The coexistence of multimorbidity and geriatric syndromes is a big character and role target to manage for the clinic works in older age, but related theories still require innovation and exploration. The disease of sympathetic overdrive (DSO) is a new hypothesis, a disease full of characteristics of organics and emotion, multiple systems, and lifestyle illness. The hypothesis of DSO might be able to explain and improve the theory about the coexistence of multimorbidity and geriatric syndromes and even more!.
摘要
共病和老年综合征的并存是老年临床工作管理的一大特点和重要目标，但相关理论仍需创新和探索。交感神经过度兴奋疾病（DSO）是一种新假说，是一种充满器质性、情感性、多系统及生活方式疾病特征的疾病。DSO假说或许能够解释并完善关于共病和老年综合征并存的理论，甚至更多！
相似文献
1
A Novel Theoretical Hypothesis on Comorbidity in the Elderly-The Disease of Sympathetic Overdrive (DSO).关于老年人共病的一种新的理论假说——交感神经过度兴奋疾病（DSO）。
Aging Med (Milton). 2025 Jul 9;8(4):370-374. doi: 10.1002/agm2.70026. eCollection 2025 Aug.
2
Interventions for improving outcomes in patients with multimorbidity in primary care and community settings.改善基层医疗和社区环境中患有多种疾病患者预后的干预措施。
Cochrane Database Syst Rev. 2016 Mar 14;3(3):CD006560. doi: 10.1002/14651858.CD006560.pub3.
3
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.改善消费者安全有效用药的干预措施：系统评价概述
Cochrane Database Syst Rev. 2014 Apr 29;2014(4):CD007768. doi: 10.1002/14651858.CD007768.pub3.
4
Sympathetic nerve blocks for persistent pain in adults with inoperable abdominopelvic cancer.成人无法手术的腹盆腔癌症持续性疼痛的交感神经阻滞。
Cochrane Database Syst Rev. 2024 Jun 6;6(6):CD015229. doi: 10.1002/14651858.CD015229.pub2.
5
Interventions for improving outcomes in patients with multimorbidity in primary care and community settings.改善基层医疗和社区环境中患有多种疾病患者治疗效果的干预措施。
Cochrane Database Syst Rev. 2012 Apr 18(4):CD006560. doi: 10.1002/14651858.CD006560.pub2.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis.帕金森病患者的身体锻炼：系统评价和网络荟萃分析。
Cochrane Database Syst Rev. 2023 Jan 5;1(1):CD013856. doi: 10.1002/14651858.CD013856.pub2.
8
Application of Machine Learning in Multimorbidity Research: Protocol for a Scoping Review.机器学习在多病种研究中的应用：系统评价方案。
JMIR Res Protoc. 2024 May 20;13:e53761. doi: 10.2196/53761.
9
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
10
The health economics of insulin therapy: How do we address the rising demands, costs, inequalities and barriers to achieving optimal outcomes.胰岛素治疗的卫生经济学：我们如何应对不断增长的需求、成本、不平等现象以及实现最佳治疗效果的障碍。
Diabetes Obes Metab. 2025 Jul;27 Suppl 5(Suppl 5):24-35. doi: 10.1111/dom.16488. Epub 2025 Jun 4.
本文引用的文献
1
Overnutrition causes insulin resistance and metabolic disorder through increased sympathetic nervous system activity.营养过剩通过增加交感神经系统活动导致胰岛素抵抗和代谢紊乱。
Cell Metab. 2025 Jan 7;37(1):121-137.e6. doi: 10.1016/j.cmet.2024.09.012. Epub 2024 Oct 21.
2
2024 ESC Guidelines for the management of elevated blood pressure and hypertension.2024年欧洲心脏病学会高血压管理指南
Eur Heart J. 2024 Oct 7;45(38):3912-4018. doi: 10.1093/eurheartj/ehae178.
3
Reliability of heart rate in reflecting cardiac sympathetic overdrive in type 2 diabetes mellitus.心率在 2 型糖尿病心脏交感神经兴奋过度中的可靠性。
Clin Auton Res. 2024 Aug;34(4):437-445. doi: 10.1007/s10286-024-01054-z. Epub 2024 Jul 22.
4
Sympathetic overactivity, hypertension and cardiovascular disease: state of the art.交感神经活性亢进、高血压与心血管疾病：最新进展。
Curr Med Res Opin. 2024;40(sup1):5-13. doi: 10.1080/03007995.2024.2305248. Epub 2024 Apr 10.
5
Evening but not morning aerobic training improves sympathetic activity and baroreflex sensitivity in elderly patients with treated hypertension.对于接受治疗的老年高血压患者，进行晚间而非晨间的有氧训练可改善交感神经活动和压力反射敏感性。
J Physiol. 2024 Mar;602(6):1049-1063. doi: 10.1113/JP285966. Epub 2024 Feb 20.
6
Mental health and lower urinary tract symptoms: Results from the NHANES and Mendelian randomization study.心理健康与下尿路症状：美国国家健康与营养检查调查及孟德尔随机化研究结果
J Psychosom Res. 2024 Mar;178:111599. doi: 10.1016/j.jpsychores.2024.111599. Epub 2024 Jan 30.
7
The Sympathetic Nervous System in Hypertensive Heart Failure with Preserved LVEF.射血分数保留的高血压性心力衰竭中的交感神经系统
J Clin Med. 2023 Oct 12;12(20):6486. doi: 10.3390/jcm12206486.
8
Role and mechanism of PVN-sympathetic-adipose circuit in depression and insulin resistance induced by chronic stress.慢性应激引起的抑郁和胰岛素抵抗中 PVN-交感-脂肪回路的作用和机制。
EMBO Rep. 2023 Dec 6;24(12):e57176. doi: 10.15252/embr.202357176. Epub 2023 Oct 23.
9
Sympathetic modulation as a goal of antihypertensive treatment: from drugs to devices.交感神经调节作为降压治疗的目标：从药物到器械。
J Hypertens. 2023 Nov 1;41(11):1688-1695. doi: 10.1097/HJH.0000000000003538. Epub 2023 Sep 4.
10
Sympathetic Neural Overdrive, Aortic Stiffening, Endothelial Dysfunction, and Impaired Exercise Capacity in Severe COVID-19 Survivors: A Mid-Term Study of Cardiovascular Sequelae.严重 COVID-19 幸存者中的交感神经过度兴奋、主动脉僵硬、内皮功能障碍和运动能力受损：心血管后遗症的中期研究。
Hypertension. 2023 Feb;80(2):470-481. doi: 10.1161/HYPERTENSIONAHA.122.19958. Epub 2022 Nov 23.
Zotero 插件